关于COVID-19中血液学并发症和治疗的审查
Armand N Yazdani1, Arian Abdi1, Prathosh Velpuri1
1College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Hematology reports
|October 24, 2023
概括
COVID-19 感染及其治疗方法可能会导致严重的血液学并发症,如血栓缩和白血缩,特别是在患有先前存在的血液疾病的患者中. 对这些易受伤害的个体来说,仔细监测和管理至关重要.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- COVID-19 (由SARS-CoV-2引起) 导致了全球显著的死亡率.
- 血液学疾病和并发症严重影响COVID-19患者的治疗结果.
- 需要对高危的血液病患者的药物治疗进行仔细管理.
研究的目的:
- 审查与COVID-19相关的血液学并发症.
- 讨论COVID-19疗法的机制和治疗组.
- 为了确定与COVID-19治疗剂相关的不良血液事件.
主要方法:
- 关于COVID-19和血液学并发症的文献综述.
- 在感染和治疗期间分析血液学变化.
- 检查常见的COVID-19疗法的不良影响.
主要成果:
- 在COVID-19患者,特别是严重病例中,血小板缺血,血红蛋白,白血病和白血球症的发病率增加.
- COVID-19疗法可以诱导血液学并发症,特别是在血液学状况的免疫功能低下患者中.
- 血液学变化可以作为疾病进展和治疗反应的生物标志物.
结论:
- 患有潜在血液病的COVID-19患者需要谨慎管理.
- 了解COVID-19治疗的血液学不良事件对于患者安全至关重要.
- 血液学监测有助于评估治疗疗效和调整策略.
相关概念视频
Hemodialysis II: Procedure and Complications
27
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
27
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Pneumonia III: Complications and Assessment
242
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
242
Disorders of Hemostasis
963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K


